amyloid beta-protein inhibitors (Neuropore Therapies)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameamyloid beta-protein inhibitors (Neuropore Therapies)
Drug Alias Nameamyloid beta-protein inhibitors (Neuropore Therapies)NPT-4003NPT-4401
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeuropore Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuropore Therapies Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A